Jim Simons Cumberland Pharmaceuticals Inc Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q2 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Cumberland Pharmaceuticals Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 494,963 shares of CPIX stock, worth $1.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

494,963

Previous 503,363 1.67%

Holding current value

$1.44 Million

Previous $2.13 Million 22.12%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$2.55 - $5.89 $21,420 - $49,476	-8,400 Reduced 1.67%	494,963 $1.66 Million
Q1 2025 May 14, 2025	SELL	$2.13 - $6.77 $8,094 - $25,726	-3,800 Reduced 0.75%	503,363 $2.13 Million
Q4 2024 Feb 13, 2025	SELL	$1.06 - $2.46 $22,260 - $51,660	-21,000 Reduced 3.98%	507,163 $1.24 Million
Q3 2024 Nov 13, 2024	SELL	$1.22 - $1.53 $12,200 - $15,300	-10,000 Reduced 1.86%	528,163 $676,000
Q2 2024 Aug 09, 2024	SELL	$1.39 - $1.78 $6,255 - $8,010	-4,500 Reduced 0.83%	538,163 $823,000
Q1 2024 May 13, 2024	SELL	$1.68 - $2.24 $12,096 - $16,128	-7,200 Reduced 1.31%	542,663 $912,000
Q4 2023 Feb 13, 2024	SELL	$1.6 - $2.14 $9,440 - $12,626	-5,900 Reduced 1.06%	549,863 $985,000
Q3 2023 Nov 14, 2023	SELL	$1.43 - $2.3 $7,121 - $11,454	-4,980 Reduced 0.89%	555,763 $1.05 Million
Q2 2023 Aug 11, 2023	SELL	$1.47 - $2.01 $16,052 - $21,949	-10,920 Reduced 1.91%	560,743 $824,000
Q1 2023 May 12, 2023	SELL	$1.92 - $2.75 $19,776 - $28,325	-10,300 Reduced 1.77%	571,663 $1.12 Million
Q4 2022 Feb 13, 2023	SELL	$2.11 - $2.6 $31,438 - $38,740	-14,900 Reduced 2.5%	581,963 $1.31 Million
Q3 2022 Nov 14, 2022	SELL	$2.06 - $2.63 $52,251 - $66,709	-25,365 Reduced 4.08%	596,863 $1.44 Million
Q2 2022 Aug 12, 2022	SELL	$1.93 - $3.03 $43,492 - $68,281	-22,535 Reduced 3.5%	622,228 $1.29 Million
Q1 2022 May 13, 2022	BUY	$2.56 - $4.98 $97,536 - $189,738	38,100 Added 6.28%	644,763 $1.82 Million
Q4 2021 Feb 11, 2022	SELL	$2.2 - $6.94 $127,382 - $401,832	-57,901 Reduced 8.71%	606,663 $2.83 Million
Q3 2021 Nov 12, 2021	SELL	$2.66 - $3.45 $98,151 - $127,301	-36,899 Reduced 5.26%	664,564 $1.78 Million
Q2 2021 Aug 13, 2021	SELL	$2.59 - $3.3 $133,618 - $170,247	-51,590 Reduced 6.85%	701,463 $2 Million
Q1 2021 May 13, 2021	BUY	$2.99 - $3.58 $232,903 - $278,860	77,894 Added 11.54%	753,053 $2.28 Million
Q4 2020 Feb 10, 2021	BUY	$2.9 - $3.3 $218,952 - $249,153	75,501 Added 12.59%	675,159 $1.99 Million
Q3 2020 Nov 13, 2020	BUY	$3.14 - $3.48 $628 - $696	200 Added 0.03%	599,658 $1.93 Million
Q2 2020 Aug 13, 2020	BUY	$3.17 - $4.01 $405,126 - $512,478	127,800 Added 27.1%	599,458 $2 Million
Q1 2020 May 14, 2020	BUY	$3.45 - $5.33 $8,004 - $12,365	2,320 Added 0.49%	471,658 $1.71 Million
Q4 2019 Feb 13, 2020	BUY	$4.68 - $5.79 $936 - $1,158	200 Added 0.04%	469,338 $2.42 Million
Q3 2019 Nov 13, 2019	BUY	$4.73 - $6.4 $130,363 - $176,390	27,561 Added 6.24%	469,138 $2.78 Million
Q2 2019 Aug 12, 2019	BUY	$5.35 - $6.8 $271,780 - $345,440	50,800 Added 13.0%	441,577 $2.81 Million
Q1 2019 May 14, 2019	BUY	$5.06 - $6.5 $47,579 - $61,119	9,403 Added 2.47%	390,777 $2.27 Million
Q4 2018 Feb 13, 2019	BUY	$5.31 - $7.0 $2.03 Million - $2.67 Million	381,374 New	381,374 $2.3 Million

Others Institutions Holding CPIX

# of Institutions

Shares Held

3.66M

Call Options Held

113K

Put Options Held

View Full List

About CUMBERLAND PHARMACEUTICALS INC

Ticker CPIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 14,661,900
Market Cap $42.7M
Description
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...

More about CPIX

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account